Ovid Therapeutics OVID
NASDAQ OVID
$2.38 -0.05 (-2.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ovid Therapeutics (OVID) Price to FCF (2021)

Updated

Ovid Therapeutics' (OVID) Price to FCF stood at 1.91 in Q4 2021, down 3.2% from the prior quarter.

Analysis

Ovid Therapeutics (OVID) Price to FCF (2021) Analysis & Trends

Starting with Q1 2021, Ovid Therapeutics' Price to FCF history includes 4 quarters.

  • Per Business Quant, the preceding three quarters came in at 1.97 (Q3 2021), 2.11 (Q2 2021) and 2.14 (Q1 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Ovid Therapeutics 439.72 Mn 71.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 1.91
Sep 30, 2021 1.97
Jun 30, 2021 2.11
Mar 31, 2021 2.14
API Access

Ovid Therapeutics Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=OVID&period=max&api_key=YOUR_API_KEY